SCHEMBL3324535

SCHEMBL3324535

CCN(CC)c1ccc(C2C(C(=O)OCc3ccccc3)=C(C)NC3=C2C(=O)CC(C)(C)C3)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 16/20 0.76
ALDH1A1 P00352 13/20 0.76
CASP1 P29466 7/20 0.76
CASP7 P55210 6/20 0.76
USP2 O75604 2/20 0.76
PKM P14618 1/20 0.76
GAA P10253 7/20 0.68
HSD17B10 Q99714 5/20 0.68
RECQL P46063 1/20 0.68
TSHR P16473 3/20 0.66
GLA P06280 3/20 0.66
SMN1; SMN2 Q16637 1/20 0.65
NOTCH1 P46531 1/20 0.57
HPGD P15428 4/20 0.54
RAB9A P51151 1/20 0.53
TP53 P04637 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
EGFR P00533 1/20 0.51
ERBB2 P04626 1/20 0.51
PDGFRB P09619 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3322661 0.90 KDM4E (0.76) KDM4EALDH1A1CASP1CASP7USP2
SCHEMBL3325456 0.87 KDM4E (0.81) KDM4EALDH1A1CASP1CASP7USP2
SCHEMBL3322699 0.85 KDM4E (0.67) KDM4EALDH1A1CASP1CASP7USP2
SCHEMBL20657021 0.83 KDM4E (0.77) KDM4EALDH1A1CASP1CASP7USP2
SCHEMBL23009202 0.83 KDM4E (0.66) KDM4EALDH1A1CASP1CASP7USP2
SCHEMBL3325303 0.82 KDM4E (0.82) KDM4EALDH1A1CASP1CASP7USP2
SCHEMBL3320741 0.82 KDM4E (0.73) KDM4EALDH1A1CASP1CASP7USP2
SCHEMBL12135812 0.82 KDM4E (0.62) KDM4EALDH1A1CASP1CASP7USP2
SCHEMBL3239096 0.81 KDM4E (0.75) KDM4EALDH1A1CASP1CASP7USP2
SCHEMBL3326688 0.81 KDM4E (0.74) KDM4EALDH1A1CASP1CASP7GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100119599-A1 POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION ARCHER PHARMACEUTICALS, INC. (US) 2010-05-13 US disclosed
US-20100119599-A1 POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION ARCHER PHARMACEUTICALS, INC. (US) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100119599-A1 POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION APP, MAPT, PSEN1 KDM4E 4115/4885ALDH1A1 2615/4885CASP1 2392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.